P
Paul L. Fine
Researcher at Atlantic Health System
Publications - 5
Citations - 837
Paul L. Fine is an academic researcher from Atlantic Health System. The author has contributed to research in topics: Nephrotic syndrome & Nephrotoxicity. The author has an hindex of 3, co-authored 4 publications receiving 793 citations.
Papers
More filters
Journal ArticleDOI
Collapsing Focal Segmental Glomerulosclerosis Following Treatment with High-Dose Pamidronate
Glen S. Markowitz,Gerald B. Appel,Paul L. Fine,Andrew Z. Fenves,Nicholas R. Loon,Sundar Jagannath,Joseph A. Kuhn,Adam D. Dratch,Vivette D. D'Agati +8 more
TL;DR: The temporal association between pamidronate therapy and the development of renal insufficiency, the use of escalating doses that exceed recommended levels, and the distinctive pattern of glomerular andtubular injury strongly suggest a mechanism of drug-associated podocyte and tubular toxicity.
Journal ArticleDOI
Toxic acute tubular necrosis following treatment with zoledronate (Zometa)
Glen S. Markowitz,Paul L. Fine,Jay I. Stack,Cheryl L. Kunis,Jai Radhakrishnan,Winicjusz Palecki,Jin Park,Samih H. Nasr,Shirley Hoh,David S. Siegel,Vivette D. D'Agati +10 more
TL;DR: The close temporal relationship between zoledronate administration and the onset of renal failure and the partial recovery of renal function following drug withdrawal strongly implicate this important and widely used agent in the development of toxic ATN.
Journal ArticleDOI
Nephrotic syndrome after treatment with pamidronate
Journal ArticleDOI
Final editorial: Principles that cut across professions and disciplines
Mark A. Fine,Paul L. Fine +1 more
RENAL BIOPSY TEACHING CASE Nephrotic Syndrome After Treatment With Pamidronate
TL;DR: The patient’s clinical course has been dominated by massive and diffuse compression fractures of the thoracic and lumbar spine, which has led to significant restrictive pulmonary disease requiring bronchodilator therapy and nocturnal oxygen supplementation.